Skip to main content

The Global Digital Pathology Market Continues To Grow Owing To the Recent Developments Done By Central Market Players in the World

 


Market Overview:

Digital pathology also offers more options for viewing, marking, and sharing images. It makes it easier for pathologists to search for cases with similar features, share slides with colleagues, and build predictive models. Using cloud storage means pathologists from around the world can access images and collaborate with one another. Using digital slides can also improve patient care. The benefits of digital pathology go beyond the ability to distribute digital slides. Digital images can be used for specialized analytics, some of which incorporate artificial intelligence. There are some downsides to digital pathology, however. It is important to weigh the benefits of digital pathology with its drawbacks. It may cause some delays in the workflow, but the benefits outweigh the disadvantages.

Competitive Landscape:

Major players operating in the global digital pathology market include Paige, Motic, Mikroscan Technologies, Kanteron Systems, Proscia Inc., PathAI, Inspirata, Inc., KONFOONG BIOTECH INTERNATIONAL CO., LTD., Glencoe Software, OptraSCAN, Sectra AB, Objective Pathology Services, Indica Labs, Corista, Akoya Biosciences, Aiforia Technologies Oy, Visiopharm A/S, Huron Digital Pathology, XIFIN, Inc., Apollo Enterprise Imaging, 3DHISTECH, F. Hoffmann-La Roche Ltd., Hamamatsu Photonics, Koninklijke Philips N.V., and Leica Biosystems.

Key Market Drivers:

Increasing developments related to the global digital pathology market are expected to augment the growth of the market, For instance, in September 2021, Visiopharm and Agilent Technologies, Inc. partnered in order to co-market Visiopharm’s CE-IVD marked Artificial Intelligence-driven Precision Pathology software, along with the automated pathology staining solutions of Agilent. Although digital pathology has only just begun to enter the clinical world, it already offers many benefits. Digital pathology tools can help pathologists make faster, more accurate diagnoses. They can also share results with other experts, and they can be shared in educational settings. The increasing expansion of pathology labs in the world is estimated to enhance the growth of the global digital pathology market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global digital pathology market. For instance, in April 2021, Paige.AI, Inc. and Leica Biosystems collaborated on Paige’s AI-enabled research software to aid in grading and tumor detection. 

Key Takeaways:

·         North America is expected to dominate the growth of the global digital pathology market, owing to the recent developments by key players in the region. For instance, in August 2020, Bio-Techne Corporation and Leica Biosystems collaborated in order to automate RNAscope COVID-19 probes on Leica’s BOND RX platform for research purposes.

·         Europe is estimated to witness high growth in the global digital pathology market, owing to the high expansion of key market players in the region. For instance, in August 2021, University Medical Center Utrecht and Sectra AB signed went in a partnership, in order to use Sectra’s pathology module.

 

Comments

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...